CP and COVID-19: These are protocols for clinical trials to evaluate the safety and efficacy of CP in treating COVID-19 patients, guidelines or programs for CP donor selection, CP preparation, laboratory examination, storage, distribution, dose, frequency and timing of CP administration, targeted patients, parameters to assess response to the treatment and long‐term outcome, adverse events, and CP application in resource-limited countries and in pediatrics and neonates.